NCT06681545 Exploring the Lived Experience of Young Adults With Severe Asthma
| NCT ID | NCT06681545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Manchester University NHS Foundation Trust |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 46 participants |
| Start Date | 2024-11-25 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 46 participants in total. It began in 2024-11-25 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Asthma is a serious long-term lung condition caused by swollen airways that narrow. This causes wheezing, chest tightness, and breathlessness. Most asthma is well-controlled with medication. However, 5-10% of asthmatics have severe asthma where treatment does not control symptoms and up to 67% of asthmatics have uncontrolled asthma, caused by not always taking medication as recommended, lifestyle choices or other health problems worsening their asthma. In the UK, asthma affects around 800,000 young adults. This group is at high-risk of having poor asthma control, worse outcomes than other age-groups. This is because young adults need care that differs from other age-groups and current care is not meeting these needs. There is little information on the experiences and needs of this group and very few studies exist, exploring how to improve care. This study will explore the experiences and needs of young adults (age16-25) with severe and uncontrolled asthma. Methods. The investigators will perform two study-arms with young adults with severe/uncontrolled asthma in Manchester and Liverpool severe asthma centres: Study-arm 1: Interview participants using photographs chosen by them to help explain their experiences of living with asthma and support that they need. Study arm 2: Perform group interviews to understand participants' thoughts around the insights from study-arm 1 combined with their own experiences. To explore and develop ideas on how to improve future care. At the end of both study arms, a workshop involving patients and stakeholders involved in delivering care will take place, to identify a joint goal of how to improve care in this cohort and map ways in which to achieve this. Together, the study results and workshop will increase our understanding of the experiences and needs of young adults with asthma. Helping us to identify new ways to improve care which can be tested in future research.
Eligibility Criteria
Inclusion Criteria: * A confirmed diagnosis of severe or uncontrolled asthma under the care of the Manchester or Liverpool severe asthma services * Participants aged 16-25 years. * Informed consent provided. Exclusion Criteria: * Inability to provide informed consent. * Participants with additional long-term conditions who identify their dominant health concern to be non-asthma related. * Focus group only- inability to converse in English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06681545 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 25 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06681545 currently recruiting?
Yes, NCT06681545 is actively recruiting participants. Contact the research team at leannejo.holmes@mft.nhs.uk for enrollment information.
Where is the NCT06681545 trial being conducted?
This trial is being conducted at Manchester, United Kingdom.
Who is sponsoring the NCT06681545 clinical trial?
NCT06681545 is sponsored by Manchester University NHS Foundation Trust. The trial plans to enroll 46 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.